GL1X · GenesisL1 explorer

Research workbench

Crystal structure of nnrti resistant K103N mutant HIV-1 reverse transcriptase in complex with dmp-266(EFAVIRENZ)

Analyse Crystal structure of nnrti resistant K103N mutant HIV-1 reverse transcriptase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1FKO
Type
protein
Length
946 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 rt, a-chain; HIV-1 rt, B-chain
EC
2.7.7.49
UniProt
P04585
Ligands
EFZ
Pockets
16 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 rt, a-chain (EC 2.7.7.49)protein54331% helix, 25% strandP04585
BHIV-1 rt, B-chain (EC 2.7.7.49)protein40335% helix, 21% strandP04585

Ligands and binding sites

  • EFZ · (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1, 4-dihydro-2H-3,1-benzoxazin-2-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19510.810.8294EFZ
26350.730.8055empty
34260.630.7740empty
44090.630.7741empty
5850.580.8720empty

Interfaces

1 interface between chains.

  • A–B · 2731 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 1FKO · Crystal structure of nnrti resistant K103N mutant HIV-1 reverse transcriptase in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.